Stock News & Analysis

What happens when a thinly traded crypto with concentrated ownership hits a rough patch? MemeCore investors found out the hard way this week.

Micron sees growth ahead for smartphones and PCs.

Hut 8 has a multigigawatt pipeline of data center projects in the works, and lucrative hyperscaler deals that have fueled a meaningful rally.

Bristol Myers Squibb leans on specialty medicines and a discounted valuation, while Johnson & Johnson boasts industry-leading margins and cash flow.

You don't have to resign yourself to being miserable.

Even if OpenAI delays its IPO, AMD stock should be fine.

This stock is literally a household name.

SoFi is back at a key price level, and a major macro shift may have just made the bull case stronger than ever.

Ark Invest bought three stocks that fell at least 5% on Thursday.

Dyne is advancing therapies for rare muscle diseases while Viking targets the booming weight-loss market. See how their financials and risk profiles compare.

Brookfield Corporation is using partnerships to build its private credit platform.

The gap between price and value on these names is getting harder to ignore by the day.

When OpenAI IPOs, AI money will flow. But when will OpenAI IPO?

XRP has delivered 900%+ returns before, so many investors are betting it can do it again. Can it?

It was beginning to look like the idea would never take hold. Then one company pounced on a once-in-a-lifetime opportunity, clearing the way for others to follow in its footsteps.

Several core tech stocks have gone on sale.

Magnite's connected TV focus contrasts with Sea's vast Southeast Asian digital empire.

Lemonade is guiding for a great 2026.

It's time to buy Nvidia, Alphabet, and Amazon.

When OpenAI IPOs, money will flow. But when will OpenAI IPO?